日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

ELDA: real-time functional drug profiling in acute lymphoblastic leukemia

ELDA:急性淋巴细胞白血病实时功能药物分析

Mariano, Samara Sousa; Assis, Leandro Henrique de Paula; Correa, Juliana Ronchi; Canevarolo, Rafael Renatino; Migita, Natacha Azussa; Sudalagunta, Praneeth Reddy; de Azevedo, Amilcar Cardoso; Meidanis, João; Brandalise, Silvia Regina; Silva, Ariosto Siqueira; Yunes, José Andrés

Genomics Define Malignant Transformation in Myeloma Precursor Conditions

基因组学定义了骨髓瘤前体疾病中的恶性转化

Maura, Francesco; Bergsagel, P Leif; Ziccheddu, Bachisio; Kumar, Shaji; Maclachlan, Kylee; Derkach, Andriy; Garces, Juan-Jose; Firestone, Ross; Braggio, Esteban; Asmann, Yan; Durante, Michael; Diamond, Benjamin T; Papadimitriou, Marios; Hultcrantz, Malin; Marella, Alessio; Castellano, Giancarlo; Maeda, Akihiro; Lionetti, Marta; Matera, Antonio; Pioggia, Stefania; Da Vià, Matteo Claudio; de Magistris, Claudio; Leongamornlert, Daniel; DeAvila, Danny; Sudalagunta, Praneeth Reddy; Canevarolo, Rafael Renatino; Siegel, Erin M; Agius, Phaedra; Teer, Jamie; McPherson, Andrew; Yamashita, Yusuke; Silva, Ariosto S; Blaney, Patrick; Baz, Rachid; Patel, Krina K; Campbell, Peter; Morgan, Gareth; Fonseca, Rafael; Landgren, Ola; Orlowski, Robert Z; Shain, Kenneth H; Bolli, Niccolo; Usmani, Saad; Rajkumar, S Vincent

The Functional Transcriptomic Landscape Informs Therapeutic Strategies in Multiple Myeloma

功能性转录组图谱为多发性骨髓瘤的治疗策略提供信息

Sudalagunta, Praneeth Reddy; Canevarolo, Rafael R; Meads, Mark B; Silva, Maria; Zhao, Xiaohong; Cubitt, Christopher L; Sansil, Samer S; DeAvila, Gabriel; Alugubelli, Raghunandan Reddy; Bishop, Ryan T; Tungesvik, Alexandre; Zhang, Qi; Hampton, Oliver; Teer, Jamie K; Welsh, Eric A; Yoder, Sean J; Shah, Bijal D; Hazlehurst, Lori; Gatenby, Robert A; Van Domelen, Dane R; Chai, Yi; Wang, Feng; DeCastro, Andrew; Bloomer, Amanda M; Siegel, Erin M; Lynch, Conor C; Sullivan, Daniel M; Alsina, Melissa; Nishihori, Taiga; Brayer, Jason; Cleveland, John L; Dalton, William; Walker, Christopher J; Landesman, Yosef; Baz, Rachid; Silva, Ariosto S; Shain, Kenneth H

Genome-level selection in tumors as a universal marker of resistance to therapy

肿瘤基因组水平选择作为治疗耐药性的普遍标志

Persi, Erez; Sudalagunta, Praneeth R; Wolf, Yuri I; Canevarolo, Rafael R; Damaghi, Mehdi; Shain, Kenneth H; Silva, Ariosto S; Koonin, Eugene V

Acid ceramidase controls proteasome inhibitor resistance and is a novel therapeutic target for the treatment of relapsed/refractory multiple myeloma

酸性神经酰胺酶控制蛋白酶体抑制剂耐药性,是治疗复发/难治性多发性骨髓瘤的新型治疗靶点。

Bishop, Ryan T; Li, Tao; Sudalagunta, Praneeth; Nasr, Mostafa; Nyman, Karl J; Alugubelli, Raghunandan R; Meads, Mark; Frieling, Jeremy; Nerlakanti, Niveditha; Tauro, Marilena; Fang, Bin; Grant, Steven; Koomen, John; Silva, Ariosto S; Shain, Kenneth H; Lynch, Conor C

Plasma cell identity escape drives resistance to anti-BCMA T-cell-redirecting therapy in multiple myeloma

浆细胞身份逃逸驱动多发性骨髓瘤对BCMA靶向T细胞重定向疗法产生耐药性

Maura, Francesco; Freeman, Ciara L; Maclachlan, Kylee H; Ilundain, Marta Larrayoz; Ziccheddu, Bachisio; Meermeier, Erin W; Garces, Juan-Jose; Durante, Michael; Lee, Holly; Firestone, Ross; Menges, Meghan; Reid, Kayla; Diamond, Benjamin; Papadimitriou, Marios; Silva, Ariosto Siqueira; Sudalagunta, Praneeth Reddy; Leblay, Noemie; Ahn, Sungwoo; Fuller, Ethan; Briercheck, Edward; Sharik, Meaghen E; Du, Megan T; Agius, Phaedra; Hansen, Doris K; Song, Xiaofei; Zhao, Xiaohong; Meads, Mark B; Teer, Jamie; Jelinek, Tomas; Hagner, Patrick; Baz, Rachid; Alsina, Melissa; Ramasubramanian, Anusuya M; Smith, Eric; Giralt, Sergio A; Mailankody, Sham; Bergsagel, Leif P; Neri, Paola; Chesi, Marta; Martinez-Climent, Jose A; Locke, Frederick L; Bahlis, Nizar J; Landgren, Ola; Hamadeh, Issam; Usmani, Saad Z; Shain, Kenneth H

Epigenetic Plasticity Drives Carcinogenesis and Multi-Therapy Resistance in Multiple Myeloma.

表观遗传可塑性驱动多发性骨髓瘤的致癌作用和多重治疗耐药性

Renatino Canevarolo Rafael, Sudalagunta Praneeth Reddy, Meads Mark B, Silva Maria, Zhao Xiaohong, Magaletti Dario, Alugubelli Raghunandan Reddy, DeAvila Gabriel, Persi Erez, Maura Francesco, Bell Elissa T, Bishop Ryan T, Cubitt Christopher L, Sansil Samer S, Zhang Wei, Teer Jamie K, Teng Mingxiang, Yoder Sean J, Siegel Erin M, Shah Bijal D, Nishihori Taiga, Hazlehurst Lori A, Lynch Conor C, Landgren Ola, Hampton Oliver, Gatenby Robert A, Sullivan Daniel M, Brayer Jason B, Dalton William S, Cleveland John L, Alsina Melissa, Baz Rachid, Shain Kenneth H, Silva Ariosto Siqueira

Unc-51 Like Kinase 3 (ULK3) is essential for autophagy and cell survival in multiple myeloma.

Unc-51 样激酶 3 (ULK3) 对多发性骨髓瘤的自噬和细胞存活至关重要

Tauro Marilena, Li Tao, Sudalagunta Praneeth R, Meads Mark, Canevarolo Rafael Renatino, Nerlakanti Niveditha, Alugubelli Raghunandan R, Lawrence Harshani R, Gunawan Steven, Ayaz Mohammad, Nareddy Pradeep, Yun Sang Young, Shay Gemma, Yang Kathy, Tran Timothy H, Bishop Ryan T, Nasr Mostafa M, Lawrence Nicholas N J, Schönbrunn Ernst, Cleveland John L, Silva Ariosto S, Shain Kenneth H, Lynch Conor C

The bone ecosystem facilitates multiple myeloma relapse and the evolution of heterogeneous drug resistant disease

骨生态系统促进多发性骨髓瘤复发和异质性耐药性疾病的演变

Ryan T Bishop #, Anna K Miller #, Matthew Froid, Niveditha Nerlakanti, Tao Li, Jeremy S Frieling, Mostafa M Nasr, Karl J Nyman, Praneeth R Sudalagunta, Rafael R Canevarolo, Ariosto Siqueira Silva, Kenneth H Shain, Conor C Lynch #, David Basanta #

Combined MEK1/2 and ATR inhibition promotes myeloma cell death through a STAT3-dependent mechanism in vitro and in vivo

体外和体内实验均表明,MEK1/2 和 ATR 联合抑制可通过 STAT3 依赖性机制促进骨髓瘤细胞死亡。

Li, Lin; Hu, Xiaoyan; Nkwocha, Jewel; Kmieciak, Maciej; Meads, Mark B; Shain, Kenneth H; Alugubelli, Raghunandan R; Silva, Ariosto S; Mann, Hashim; Sudalagunta, Praneeth R; Canevarolo, Rafael R; Zhou, Liang; Grant, Steven